Published in AJR Am J Roentgenol on July 01, 2012
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol (2015) 1.03
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol (2014) 0.81
Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol (2014) 0.80
Split-bolus versus triphasic multidetector-row computed tomography technique in the diagnosis of hepatic focal nodular hyperplasia: a case report. J Med Case Rep (2014) 0.78
Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol (2013) 0.77
Hepatic focal nodular hyperplasia in children: imaging features on multi-slice computed tomography. World J Gastroenterol (2012) 0.75
Use of contrast agents in oncological imaging: magnetic resonance imaging. Cancer Imaging (2013) 0.75
A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol (2017) 0.75
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Review of internal hernias: radiographic and clinical findings. AJR Am J Roentgenol (2006) 5.32
Phase I trial of pazopanib in patients with advanced cancer. Clin Cancer Res (2009) 2.63
Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology (2012) 2.51
Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology (2011) 2.42
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34
Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology (2015) 2.11
Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96
Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study. Radiology (2009) 1.90
Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology (2008) 1.84
ACR Appropriateness Criteria® acute onset flank pain--suspicion of stone disease. Ultrasound Q (2012) 1.76
Endovascular treatment of visceral artery aneurysms. J Endovasc Ther (2002) 1.75
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol (2010) 1.70
Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging (2010) 1.70
Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65
Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology (2008) 1.62
What is the current role of CT urography and MR urography in the evaluation of the urinary tract? Radiology (2009) 1.61
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol (2012) 1.58
ACR Appropriateness Criteria ® acute onset of scrotal pain--without trauma, without antecedent mass. Ultrasound Q (2012) 1.57
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Contrast-enhanced magnetic resonance urography at 3T: clinical feasibility. J Comput Assist Tomogr (2013) 1.44
Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology (2008) 1.41
Characterizing solid renal neoplasms with MRI in adults. Abdom Imaging (2014) 1.39
Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post-prostatectomy hernia. BJU Int (2012) 1.39
Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology (2010) 1.38
Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population. Intern Med (2012) 1.38
A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am (2007) 1.37
Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol (2011) 1.37
Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol (2010) 1.33
Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol (2009) 1.23
MR findings in knee osteoarthritis. Eur Radiol (2002) 1.21
Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol (2010) 1.18
Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol (2010) 1.17
MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol (2005) 1.16
Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging (2013) 1.11
Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol (2010) 1.11
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology (2006) 1.07
T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.05
Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol (2004) 1.04
Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol (2011) 1.04
Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. Hepatology (2012) 1.03
Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging (2012) 1.03
Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging (2014) 1.02
Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology (2004) 1.02
Perspectives on body MR imaging at ultrahigh field. Magn Reson Imaging Clin N Am (2007) 1.00
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. J Am Coll Radiol (2013) 1.00
CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics (2007) 0.99
Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology (2004) 0.98
Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging (2010) 0.98
Time-resolved MR angiography as a useful sequence for assessment of ovarian vein reflux. AJR Am J Roentgenol (2009) 0.98
Calcified vascular plaque specimens: assessment with cardiac dual-energy multidetector CT in anthropomorphically moving heart phantom. Radiology (2008) 0.97
MRI of pelvic floor dysfunction: dynamic true fast imaging with steady-state precession versus HASTE. AJR Am J Roentgenol (2008) 0.96
Body and cardiovascular MR imaging at 3.0 T. Radiology (2007) 0.96
Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance. AJR Am J Roentgenol (2006) 0.96
Identification of vertebral fractures in osteoporosis. Semin Musculoskelet Radiol (2002) 0.96
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96
Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra. Rev Urol (2008) 0.95
Multislice helical CT of the pancreas and spleen. Eur J Radiol (2003) 0.95
Focal cystic high-attenuation lesions: characterization in renal phantom by using photon-counting spectral CT--improved differentiation of lesion composition. Radiology (2010) 0.94
Abdominal 4D flow MR imaging in a breath hold: combination of spiral sampling and dynamic compressed sensing for highly accelerated acquisition. Radiology (2014) 0.94
MRI of the pelvis in women: 3D versus 2D T2-weighted technique. AJR Am J Roentgenol (2010) 0.94
Central veins of the chest: evaluation with time-resolved MR angiography. Radiology (2008) 0.93
Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol (2008) 0.93
N/2 ghosting artifacts: elimination at 3.0-T MR cholangiography with SPACE pulse sequence. Radiology (2008) 0.93
Coronary stent patency: dual-energy multidetector CT assessment in a pilot study with anthropomorphic phantom. Radiology (2008) 0.93
Diffusion and perfusion imaging of the liver. Eur J Radiol (2010) 0.92
Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. AJR Am J Roentgenol (2009) 0.92
Differentiating a chronic hyperplastic mass from pancreatic cancer: a challenge remaining in multidetector CT of the pancreas. Eur Radiol (2003) 0.91
Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol (2010) 0.91
Intrahepatic portal cavernoma as an indication for liver transplantation. Liver Transpl (2007) 0.91
Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology (2003) 0.90
Frequency and CT patterns of bowel wall thickening proximal to cancer of the colon. AJR Am J Roentgenol (2004) 0.90
Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am (2010) 0.90
Improvement in B1-inhomogeneity artifacts in the abdomen at 3T MR imaging using a radiofrequency cushion. J Magn Reson Imaging (2008) 0.90
Multi-detector row CT of the small bowel: peak enhancement temporal window--initial experience. Radiology (2007) 0.89
Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? J Magn Reson Imaging (2011) 0.89
Abdominal magnetic resonance imaging at 3.0 T what is the ultimate gain in signal-to-noise ratio? Acad Radiol (2006) 0.88
DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging (2013) 0.88
Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. Magn Reson Imaging Clin N Am (2009) 0.88
Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging (2009) 0.88
Do surgical clips interfere with radiofrequency thermal ablation? AJR Am J Roentgenol (2003) 0.87
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87
Assessment of automatic vessel tracking techniques in preoperative planning of transluminal aortic stent graft implantation. J Comput Assist Tomogr (2004) 0.87
Comparison of ECG-gated rectilinear vs. real-time radial K-space sampling schemes in cine True-FISP cardiac MRI. J Cardiovasc Magn Reson (2004) 0.87
Diffusion-weighted MR imaging for liver lesion characterization: a critical look. Radiology (2012) 0.86
Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol (2011) 0.86
Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology (2008) 0.86
Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. AJR Am J Roentgenol (2010) 0.86
Practice patterns in imaging of the pregnant patient with abdominal pain: a survey of academic centers. AJR Am J Roentgenol (2007) 0.86
Abdominal pain: coronal reformations from isotropic voxels with 16-section CT--reader lesion detection and interpretation time. Radiology (2007) 0.86
Detection of renal lesion enhancement with dual-energy multidetector CT. Radiology (2011) 0.86
Characterization of adrenal pheochromocytoma using respiratory-triggered proton MR spectroscopy: initial experience. AJR Am J Roentgenol (2009) 0.85
Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? Eur J Radiol (2010) 0.85
Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics (2009) 0.85
Diffusion-weighted MR imaging of the kidneys and the urinary tract. Magn Reson Imaging Clin N Am (2008) 0.84